According to the Agency for Healthcare Research and Quality (AHRQ), chronic obstructive pulmonary disease (COPD) is the fourth-leading cause of death in the United States and also results in a high number of emergency department visits and hospitalizations.
Proper management of COPD exacerbation — including pharmacotherapy in the form of bronchodilators, antibiotics and oral steroids — can help reduce the clinical and economic impacts of this disease.
May 1, 2010